Canada Fill-finish Pharmaceutical Contract Manufacturing Market Size & Outlook
Canada fill-finish pharmaceutical contract manufacturing market, 2018-2030 (US$M)
Related Markets
Canada fill-finish pharmaceutical contract manufacturing market highlights
- The Canada fill-finish pharmaceutical contract manufacturing market generated a revenue of USD 149.5 million in 2023 and is expected to reach USD 211.7 million by 2030.
- The Canada market is expected to grow at a CAGR of 5.1% from 2024 to 2030.
- In terms of segment, large molecules was the largest revenue generating molecule type in 2023.
- Small molecules is the most lucrative molecule type segment registering the fastest growth during the forecast period.
Fill-finish pharmaceutical contract manufacturing market data book summary
| Market revenue in 2023 | USD 149.5 million |
| Market revenue in 2030 | USD 211.7 million |
| Growth rate | 5.1% (CAGR from 2023 to 2030) |
| Largest segment | Large molecules |
| Fastest growing segment | Small molecules |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Large Molecules, Small molecules |
| Key market players worldwide | Boehringer Ingelheim, Catalent Inc, Baxter International Inc, Eurofins Scientific SE, Recipharm, Fresenius SE & Co KGaA, Novartis AG ADR, Recro Pharma, Symbiosis Pharmaceutical Services, MabPlex International |
Other key industry trends
- In terms of revenue, Canada accounted for 1.6% of the global fill-finish pharmaceutical contract manufacturing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. fill-finish pharmaceutical contract manufacturing market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 4,022.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Fill-finish Pharmaceutical Contract Manufacturing Market Scope
Fill-finish Pharmaceutical Contract Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada fill-finish pharmaceutical contract manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fill-finish pharmaceutical contract manufacturing market will help companies and investors design strategic landscapes.
Large molecules was the largest segment with a revenue share of 67.09% in 2023. Horizon Databook has segmented the Canada fill-finish pharmaceutical contract manufacturing market based on large molecules, small molecules covering the revenue growth of each sub-segment from 2018 to 2030.
The fill-and-finish pharmaceutical contract manufacturing market in Canada is highly competitive, with several key players operating in the region. Some major players are Patheon, Inc., Jubilant, Recipharm AB, Novartis, and Lonza. These players compete on factors such as product quality, reliability, capacity, and cost-effectiveness to attract & retain clients.
Reasons to subscribe to Canada fill-finish pharmaceutical contract manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada fill-finish pharmaceutical contract manufacturing market databook
-
Our clientele includes a mix of fill-finish pharmaceutical contract manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada fill-finish pharmaceutical contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Canada fill-finish pharmaceutical contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada fill-finish pharmaceutical contract manufacturing market size, by molecule type, 2018-2030 (US$M)
Canada Fill-finish Pharmaceutical Contract Manufacturing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
